Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers

Psychopharmacology

Volumn 165, Issue 4, 2003, Pages 419-429

  Allain, H ^a   Tessier, C ^b   Bentue Ferrer D ^a   Tarral, A ^c   Le Breton, S ^c   Gandon, J M ^c   Bouhours, P ^b  

^a UNIVERSITÉ DE RENNES 1   (France)

^b Laboratoires Janssen CILAG   (France)

^c Biotrial SA   (France)

Author keywords

Bridging study; Cognitive functions; Healthy elderly volunteers; Risperidone

Indexed keywords

LORAZEPAM; NEUROLEPTIC AGENT; PALIPERIDONE; RISPERIDONE;

AGED; ALERTNESS; ANXIETY; AROUSAL; ARTICLE; ASTHENIA; BACKACHE; BALANCE DISORDER; BODY POSTURE; BRADYKINESIA; CLINICAL TRIAL; CONSCIOUSNESS DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTITIS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SAFETY; ELECTROCARDIOGRAM; ELECTROENCEPHALOGRAM; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; JOB PERFORMANCE; LABORATORY TEST; LONG TERM MEMORY; LOW DRUG DOSE; MALE; MOTOR DYSFUNCTION; NORMAL HUMAN; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SIDE EFFECT; SINGLE DRUG DOSE; TRACHEITIS; VISUAL DISORDER;

EID: 0037321872     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1272-2     Document Type: Article

References (46)

1. Allain H, Schück S, Bentué-Ferrer D, Bourin M, Vercelletto M, Reymann JM, Polard E (2000a) Anxiolytics in the treatment of behavioral and psychological symptoms of dementia. Int Psychogeriatr 12:281-289
2. Allain H, Dautzenberg PHJ, Maurer K, Schück S, Bonhomme D, Gérard D (2000b) Double blind study of tiapride versus haloperidol and placebo in agitation and aggressiveness in elderly patients with cognitive impairment. Psychopharmacology 148:361-366
3. Allain H, Schück S, Mauduit N, Djemai M (2001) Comparative effects of pharmacotherapy on the maintenance of cognitive function. Eur Psychiatry 16:35s-41s
4. Arciniegas DB, Topkoff JL, Held K, Frey L (2001) Psychosis due to neurologic conditions. Curr Treat Options Neurol 3:347-366
5. Beuzen JN, Taylor N, Wesnes K, Wood A (1999) A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers. J Psychopharmacol 13:152-158
6. Bhana N, Spencer CM (2000) Risperidone: a review of its use in the management of the behavioural and psychological symptoms of dementia. Drugs Aging 16:451-471
7. Bond A, Lader M (1974) The use of analogue scales in rating subjective feeling. Br J Med Psychol 47:211-218
8. th Congress of the International Psychogeriatric Association, Jerusalem, August 17-22 (Abstract)
9. Curran V, Allen D, Lader M (1987) The effect of single dose of alpidem and lorazepam on memory and psychomotor performance in normal humans. J Psychopharmacol 2:81-89
10. Daniel DG (2000) Antipsychotic treatment of psychosis and agitation in the elderly. J Clin Psychiatry 61 (Suppl 14):49-52
11. De Deyn PP, Rabheru K, Rasmussen A, Bocksberger JP, Dautzenberg PL, Eriksson S, Lawlor BA (1999) A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology 53:946-955
12. Edell WS, Tunis SL (2001) Antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric inpatients. Am J Geriatr Psychiatry 9:289-297
13. Falsetti AE (2000) Risperidone for control of agitation in dementia patients. Am J Health Syst Pharm 57:862-870
14. File SE, Bond AS (1979) Impaired performance and sedation after a single dose of lorazepam. Psychomarmacology 66:309-313
15. Gandon JM, Allain MD (2002) Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers. Br J Clin Pharmacol 54:51-58
16. Gareri P, Cotroneo A, Marchisio U, Curcio M, De Sarro G (2001) Risperidone in the treatment of behavioral disorders in elderly patients with dementia. Arch Gerontol Geriatr 33 (Suppl 1):173-182
17. Glick ID, Murray SR, Vasudevan P, Marder SR, Hu RJ (2001) Treatment with atypical antipsychotics: new indications and new populations. J Psychiatr Res 35:187-191
18. Grant S, Fitton A (1994) Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia. Drugs 48:253-273
19. Hindmarch I, Gudgeon AC (1980) The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability. Br J Clin Pharmacol 10:145-150
20. Holland RL, Wesnes K, Dietrich B (1994) Single dose human pharmacology of umespirone. Eur J Clin Pharmacol 46:461-468
21. Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolinato J, Brecher M (1999) Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry 60:107-115
22. Madhusoodanan S, Brenner R, Cohen CI (1999) Role of atypical antipsychotics in the treatment of psychosis and agitation associated with dementia. CNS Drugs 12:135-150
23. McClelland GR (1989) Body sway and the effects of psychoactive drug. A review. Hum Psychopharmacol 4:3-14
24. McShane R, Keene J, Gedling K, Fairburn C, Jacoby R, Hope T (1997) Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up. BMJ 314:266-270
25. Nowakowska E, Chodera A, Kus K (1999) Influence of olanzapine on cognitive functions and catalepsy in rats after single and chronic administration. Pol J Pharmacol 51:295-300
26. Parkin C, Fairweather DB, Shamsi N, Stanley N, Hindmarch I (1998) The effects of cigarette smoking on overnight performance. Psychopharmacology 136:172-178
27. Patat A (2000) Clinical pharmacology of psychotropic drugs. Hum Psychopharmacol Clin Exp 15:361-387
28. Patat A, Klein MJ, Surjus A, Rostand A, Granier J (1991) Study of effects of clobazam and lorazepam on memory and cognitive functions in healthy subjects. Hum Psychopharmacol 6:229-241
29. Patat A, Alberini H, Bonhomme D, Soubrane C, Allain H, Gandon JM (1999a) Effects of tiapride on electroencephalograms and cognitive functions in the elderly. Int Clin Psychopharmacol 14:199-208
30. Patat A, Rosenzweig P, Migret N, Allain H, Gandon JM (1999b) Effects of 50 mg amisulpride on EEG, psychomotor and cognitive functions in healthy sleep-deprived subjects. Fundam Clin Pharmacol 13:582-594
31. Potenza MN, McDougle JM (1998) Potential of atypical antipsychotics in the treatment of nonpsychotic disorders. CNS Drugs 9:213-232
32. Preston GD, Broks P, Traub M, Ward C, Poppleton P, Stahl SM (1988) Effects of lorazepam on memory, attention and sedation in man. Psychopharmacology 95:208-215
33. Reynolds PI, Strayer SM (2000) Neuroleptics for behavioral symptoms of dementia. J Fam Pract 49:78-79
34. Rosvold ME, Mirsky AF, Sarason I, Bransome ER Jr, Beck LH (1956) A continuous performance test for brain damage. J Consult Clin Psychol 20:343-350
35. Sacristan JA, Gomez JC, Montejo AL, Vieta E, Gregor KJ, EFESO Study Group (2000) Doses of olanzapine, risperidone, and haloperidol used in clinical practice: results of a prospective pharmacoepidemiologic study. Clin Ther 22:583-599
36. Salzman C (2001) Treatment of the agitation of late-life psychosis and Alzheimer's disease. Eur Psychiatry 16:25-28
37. Schück S, Bentué-Ferrer D, Kleinermans D, Reymann JM, Polard E, Gandon JM, Allain H (2002) Psychomotor and cognitive effects of piribedil, a dopamine agonist, in young healthy volunteers. Fundam Clin Pharmacol 16:57-65
38. Schweitzer I (2001) Does risperidone have a place in the treatment of nonschizophrenic patients? Int Clin Psychopharmacol 16:1-19
39. Seppala T, Korttila K, Hakkinen S, Linnoila M (1976) Residual effects and skills related to driving after single oral administration of diazepam, mediazepam or lorazepam. Br J Clin Pharmacol 3:831-841
40. Snoeck E, Van Peer A, Sack M, Horton M, Mannens G, Woestenborghs R, Meibach R, Heykants J (1995) Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man. Psychopharmacology 122:223-229
41. Steele C, Rovner B, Chase GA, Folstein M (1990) Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry 147:1049-1051
42. Sternberg S (1969) Memory scanning: memory processes revealed by reaction time experiments. Am Sci 57:421-457
43. Verma S, Orengo C, Kunik ME, Hale D, Molinari VA (2001) Tolerability and effectiveness of atypical antipsychotics in male geriatric inpatients. Int J Geriatr Psychiatry 16:223-227
44. Williams R (2001) Optimal dosing with risperidone: updated recommendations. J Clin Psychiatry 62:282-289
45. Zarate CA, Baldessarini RJ, Siegel AJ, Nakamura A, McDonald J, Muir-Hutchinson LA, Cherkerzian T, Tohen M (1997) Risperidone in the elderly: a pharmacoepidemiologic study. J Clin Psychiatry 58:311-317
46. Zaudig M (2000) A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia. Drug Saf 23:183-195